Time to Ambulation After ProGlide Closure
Recruiting
N/A
Interventional Study
Femoral Access Site Closure
Ambulation
Vascular Access Complication
Vascular Access Site Management
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 300 (estimated)
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Transradial access has become the standard for coronary procedures due to fewer vascular complications and shorter bed rest, yet transfemoral access remains essential for complex peripheral interventions requiring larger sheaths and stronger support. Vascular closure devices (VCDs), particularly suture-mediated devices such as ProGlide, have improved femoral access by reducing hemostasis time, amb…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Scheduled for peripheral angiography or endovascular intervention via transfemoral access.
* Femoral artery puncture site located at the common femoral artery.
* Use of 6-8F vascular sheath.
* Hemostasis achieved with 6F ProGlide closure device (defined as no active bleeding, …
Contacts